An experimental cancer vaccine from GlaxoSmithKline has failed in a second test - this time against lung cancer - but the British company said it still hoped to identify a sub-group of patients on which it would work.
http://ift.tt/1oz5D3A
http://ift.tt/1oz5D3A
No comments:
Post a Comment